38 CFR Part 4, Rating Schedule

38 CFR § 4.117

Schedule of ratings-hemic and lymphatic systems

Cited in any decision rating a blood cancer, anemia, clotting disorder, or related blood or lymph condition.

How the Board actually uses this section

Original RateMyVSO research, catalogued from the full archive of published Board of Veterans' Appeals decisions. No other source measures how each regulation plays out at the Board.

44.6%
granted at least one issue
2,252
published decisions citing it

The grant figure reflects the mix of claims where this section comes up, not the legal merit of any single claim.

Read the 2,252 decisions citing § 4.117

The conditions it decides

Decision counts per diagnostic code. Select a bar to read those exact Board decisions.

What this regulation says, in plain English

This is VA's rating schedule for blood and lymphatic system conditions, including leukemia, lymphoma, multiple myeloma, sickle cell anemia, aplastic anemia, and various anemias and clotting disorders. Cancer-type conditions in this schedule typically get a temporary 100 percent rating during active disease or treatment, then a mandatory follow-up exam sets the rating for any lasting residuals.

Read the full text of 38 CFR § 4.117

This text was last amended by VA on October 20, 2022. We check it against eCFR every week.

See the full table on eCFR.

(Authority: 38 U.S.C. 1155)

RateMyVSO. Educational aggregate of published Board of Veterans' Appeals decisions and 38 CFR text. Not affiliated with the VA. Not legal advice. Find a VSO representative.